Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Liabilities and Shareholders Equity (2016 - 2025)

Proto Labs' Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $763.4 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 2.68% year-over-year to $763.4 million; the TTM value through Dec 2025 reached $3.0 billion, down 0.8%, while the annual FY2025 figure was $763.4 million, 2.68% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $763.4 million at Proto Labs, up from $756.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $949.3 million in Q2 2021 and bottomed at $737.4 million in Q1 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $780.7 million (2023), against an average of $822.8 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 37.81% in 2021 before it dropped 15.4% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $928.6 million in 2021, then fell by 13.61% to $802.2 million in 2022, then decreased by 3.72% to $772.4 million in 2023, then fell by 3.73% to $743.5 million in 2024, then grew by 2.68% to $763.4 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Liabilities and Shareholders Equity are $763.4 million (Q4 2025), $756.9 million (Q3 2025), and $743.3 million (Q2 2025).